Lionberger R - Search Results

1

Generic lamotrigine versus brand-name Lamictal bioequivalence in patients with epilepsy: A field test of the FDA bioequivalence standard.

Ting TY, Jiang W, Lionberger R, Wong J, Jones JW, Kane MA, Krumholz A, Temple R, Polli JE. Ting TY, et al. Among authors: lionberger r. Epilepsia. 2015 Sep;56(9):1415-24. doi: 10.1111/epi.13095. Epub 2015 Jul 23. Epilepsia. 2015. PMID: 26201987 Free article.

2

Impact of P-glycoprotein-mediated intestinal efflux kinetics on oral bioavailability of P-glycoprotein substrates.

Kwon H, Lionberger RA, Yu LX. Kwon H, et al. Mol Pharm. 2004 Nov-Dec;1(6):455-65. doi: 10.1021/mp049921x. Mol Pharm. 2004. PMID: 16028357

3

Bioequivalence approaches for highly variable drugs and drug products.

Haidar SH, Davit B, Chen ML, Conner D, Lee L, Li QH, Lionberger R, Makhlouf F, Patel D, Schuirmann DJ, Yu LX. Haidar SH, et al. Among authors: lionberger r. Pharm Res. 2008 Jan;25(1):237-41. doi: 10.1007/s11095-007-9434-x. Epub 2007 Sep 22. Pharm Res. 2008. PMID: 17891552 Review.

4

FDA critical path initiatives: opportunities for generic drug development.

Lionberger RA. Lionberger RA. AAPS J. 2008;10(1):103-9. doi: 10.1208/s12248-008-9010-2. Epub 2008 Feb 20. AAPS J. 2008. PMID: 18446510 Free PMC article. Review.

5

Quality by design: concepts for ANDAs.

Lionberger RA, Lee SL, Lee L, Raw A, Yu LX. Lionberger RA, et al. AAPS J. 2008 Jun;10(2):268-76. doi: 10.1208/s12248-008-9026-7. Epub 2008 May 9. AAPS J. 2008. PMID: 18465252 Free PMC article.

6

Generic omeprazole delayed-release capsules: in vitro performance evaluations.

Moore T, Smith A, Ye W, Toler DY, Westenberger BJ, Lionberger R, Raw A, Yu L, Buhse LF. Moore T, et al. Among authors: lionberger r. Drug Dev Ind Pharm. 2009 Aug;35(8):917-21. doi: 10.1080/03639040802698802. Drug Dev Ind Pharm. 2009. PMID: 19555236

7

Analysis of bead sizes for MR capsules labeled for sprinkle.

Nagavelli LR, Lionberger RA, Sayeed VA, Yu L, Allgire J, Smith A, Wokovich A, Westenberger BJ, Buhse L. Nagavelli LR, et al. Among authors: lionberger ra. AAPS PharmSciTech. 2010 Dec;11(4):1508-10. doi: 10.1208/s12249-010-9529-2. Epub 2010 Oct 9. AAPS PharmSciTech. 2010. PMID: 20936439 Free PMC article.

8

Utility of physiologically based absorption modeling in implementing Quality by Design in drug development.

Zhang X, Lionberger RA, Davit BM, Yu LX. Zhang X, et al. AAPS J. 2011 Mar;13(1):59-71. doi: 10.1208/s12248-010-9250-9. Epub 2011 Jan 5. AAPS J. 2011. PMID: 21207216 Free PMC article.

9

Pharmaceutical equivalence by design for generic drugs: modified-release products.

Raw AS, Lionberger R, Yu LX. Raw AS, et al. Among authors: lionberger r. Pharm Res. 2011 Jul;28(7):1445-53. doi: 10.1007/s11095-011-0397-6. Epub 2011 Mar 9. Pharm Res. 2011. PMID: 21387150

10

Using partial area for evaluation of bioavailability and bioequivalence.

Chen ML, Davit B, Lionberger R, Wahba Z, Ahn HY, Yu LX. Chen ML, et al. Among authors: lionberger r. Pharm Res. 2011 Aug;28(8):1939-47. doi: 10.1007/s11095-011-0421-x. Epub 2011 Apr 13. Pharm Res. 2011. PMID: 21487930 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results